Skip to evidence report

FIB.transitioning.ISG_primed_interface: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 306 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.transitioning.ISG_primed_interface
#Trait / studyIndividual trait IDMean IC score
1Gestational age at birth (child effect)GCST9026842178.50
2Osteoporosis NOS (PheCode 743.11)GCST9047626076.50
3Osteoporosis (PheCode 743.1)GCST9047625969.98
4Sleep apnea (MTAG) (adjusted for BMI)GCST9026736454.67
5T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77)GCST9032089651.04
6IDP T1 FIRST left putamen volumeGCST9000244050.70
7Other specified and unspecified disorders of lensFING0000110147.07
8DTI autoptx FA str r tractGCST9038513643.26
9DTI autoptx L2 str r tractGCST9038519042.75
10aparc-DKTatlas rh volume parahippocampalGCST9000290740.60
11BA-exvivo lh volume BA3aGCST9000283738.41
12height (minimum, inv-normal transformed)GCST9047536538.39
13Hereditary corneal dystrophiesFING0000061138.39
14DTI autoptx FA slf l tractGCST9038513338.33
15What is your height? (cm, inv-normal transformed)GCST9047536837.47
16height (mean, inv-normal transformed)GCST9047536237.23
17Height (maximum, inv-normal transformed)GCST9047535936.43
18DTI autoptx MD cgc r tractGCST9038522536.27
19Phosphatidylcholine (14:0_22:6) levelsGCST9002423435.81
20BCAN/NPTXR ratioGCST9031348235.59
21EGFR/FAP ratioGCST9031461335.42
22Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST9047625835.00
23ScoliosisFING0000128134.82
24DTI autoptx L3 str r tractGCST9038521734.70
25Forced vital capacity (FVC) | SpirometryUKBB0000025434.68
26Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241134.35
27DTI TBSS FA Superior longitudinal fasciculus LGCST9038442133.37
28Volume of left paralaminar nucleusGCST9047498532.92
29ALB levelsGCST9047510631.32
30ADAMTSL2 levelsGCST9046822830.66
31aparc-DKTatlas rh area lateraloccipitalGCST9000327430.65
32Spinal stenosis | musculoskeletalUKBB0000079230.59
33Operation code - spine or back surgery | OperationsUKBB0000056530.16
34DTI autoptx L3 str l tractGCST9038521629.95
35Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivityGCST9030273329.55
36aparc-Desikan rh volume parahippocampalGCST9000281629.51
37Alpha angleGCST9012963529.46
38aparc-Desikan lh thickness GlobalMeanThicknessGCST9000344529.14
39SIL1 levelsGCST9047063829.13
40T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 80)GCST9032064328.99
41Standing height (UKB data field 50)GCST9046817828.80
42aparc-a2009s rh area Pole-occipitalGCST9000341228.32
43ALB levelsGCST9047510328.09
44PDCD6 levelsGCST9047018327.72
45Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary OperationsUKBB0000058727.67
46ASPN levelsGCST9046837727.58
47Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB0000006727.47
48T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 103)GCST9032092227.30
49IDP T1 FAST ROIs R occ poleGCST9000254627.24
50ITGA2 levelsGCST9046963427.10
51T1 FreeSurfer a2009s lh G cuneus areaGCST9038467827.08
52Intraocular pressure (confirmatory factor analysis Factor 26)GCST9030936027.03
53Left-hemisphere control network to putamen white-matter structural connectivityGCST9030275426.79
54Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB0000037726.70
55aparc-DKTatlas lh area pericalcarineGCST9000325326.60
56Sitting height | Body size measuresUKBB0000077126.60
57Height (baseline)GCST9056584326.41
58aparc-Desikan rh area lateraloccipitalGCST9000311726.29
59Forced expiratory volume in 1-second (FEV1), predicted | SpirometryUKBB0000025226.28
60HeightGCST9030289026.22
61Ribothymidine levels in chronic kidney diseaseGCST9025755426.14
62Pulse pressureGCST9047278525.95
63RFC4 levelsGCST9047046025.87
64Carpal tunnel syndromeFING0000025725.58
65IGFBP3 levelsGCST9046952925.54
66T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST9032092125.47
67Seated height | Body size measuresUKBB0000076325.15
68Sulcal opening distance of the right calloso-marginal posterior fissureGCST9010494624.95
69ANGPTL2 levelsGCST9046830324.92
70BA-exvivo lh area V1GCST9000321624.51
71HeightGCST9027863724.50
72PADI2 levelsGCST9047014224.44
73MTHFSD levelsGCST9046995624.33
74FAP levelsGCST9046918924.09
75Fracture of forearmGCST9028127323.94
76Pulse pressureGCST9030170323.91
77Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressureUKBB0000037623.83
78T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST9032060923.56
79Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207523.42
80Coronary atherosclerosisFING0000035923.38
81RAD23B levelsGCST9047041823.17
82Bioavailable testosterone levelsGCST9001210423.12
83HEXIM1/IKBKG ratioGCST9031504523.00
84Central corneal thicknessGCST00636622.99
85Appendicular lean massGCST9000002622.97
86Hallux valgus (Bunion) (PheCode 735.3)GCST9047625122.89
87Perforation of tympanic membraneFING0000115522.70
88Pulse pressureGCST9030170122.63
89Calcific aortic valvular stenosis, operatedFING0000023422.48
90Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22)GCST9047599122.32
91HerniaFING0000061622.23
92Autorefraction - 6mm asymmetry index (right) | EyesightUKBB0000007422.21
93Deep biteFING0000038022.15
94REST UKBBICA NET100 1287GCST9038714122.11
95Occlusion and stenosis of precerebral arteries (PheCode 433.1)GCST9047598622.08
96Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST9020009822.01
97aparc-Desikan lh area pericalcarineGCST9000309321.87
98HeightGCST9002594921.81
99Height (standard GWA)GCST9026728421.59
100Appendicular lean massGCST9000002521.42
101Lung function (FVC)GCST00742921.27
102Abdominal aortic aneurysm (PheCode 442.11)GCST9047599421.16
103PALM2 levelsGCST9047015221.07
104Waist-to-Hip ratio | Body measurementUKBB0000090521.03
105PTGES2 levelsGCST9047036921.02
106Ventral hernia (PheCode 550.5)GCST9047606320.88
107Hallux valgus (acquired)FING0000060120.76
108UBE2L6 levelsGCST9047100120.75
109Ischaemic heart disease, wide definitionFING0000070320.66
110Succinylcarnitine levelsGCST9024387420.65
111Anterior thigh muscle volumeGCST9026734920.62
112Left-hemisphere visual network to thalamus white-matter structural connectivityGCST9030266220.59
113Hard cardiovascular diseasesFING0000060220.59
114Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050258020.57
115Inguinal hernia | digestiveUKBB0000036220.45
116Aortic aneurysm (PheCode 442.1)GCST9047599320.36
117Takes medication for acid reflux/GERD?GCST9047532120.32
118ANGPTL3/TFPI ratioGCST9031327020.27
119aseg global volume CC-PosteriorGCST9000260720.22
120T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST9032094020.17
121Plasma N-acetylhistidine levels in chronic kidney diseaseGCST9026557620.14
122Hereditary ataxiaFING0000061020.11
123Waist-to-hip ratio adjusted for BMIGCST9002599620.09
124DTI autoptx L2 slf l tractGCST9038518719.93
125CTSO levelsGCST9046891519.85
126aparc-pial rh area lateraloccipitalGCST9000318419.80
127Physical function (baseline)GCST9056583719.68
128C-reactive protein levels (CRP.4337.49.2)GCST9024050319.64
129CDKN1A/FXN ratioGCST9031397119.61
130IL1RL1 levelsGCST9024158119.57
131BST2 levelsGCST9046847519.57
132Other cancerGCST9047518119.51
133Autorefraction - 3mm cylindrical power (left) | EyesightUKBB0000006219.49
134Forced vital capacity FVC Z score (UKB data field 20257)GCST9046816719.43
135Other aneurysm (PheCode 442)GCST9047599219.40
136Pulse pressureGCST9030170219.39
137Fracture of forearmFING0000055419.29
138Macular puckering of retina (PheCode 362.26)GCST9047585419.24
139GLB1/PCSK9 ratioGCST9031493319.06
140Appendicular lean massGCST9000002718.93
141COL24A1 levelsGCST9046881418.83
142Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST9006018918.79
143Coronary artery bypass graftingFING0000035818.73
144Abdominal hernia (PheCode 550)GCST9047605918.72
145rfMRI connectivity (ICA100 edge 380)GCST9000523318.71
146X-24947 levelsGCST9020065118.57
147PCSK9 levelsGCST9042811018.56
148HeightGCST9001873918.56
149NAAA levelsGCST9046999118.53
150Myopia (PheCode 367.1)GCST9047588018.52
151Height, inverse-rank normalizedFING0000060718.49
152CTSO levelsGCST9017927718.46
153Other disorders of corneaFING0000102218.41
154Phosphatidylcholine (40:8) levelsGCST9002553818.38
155Emphysema (PheCode 496.1)GCST9047602818.37
156Coronary atherosclerosis (PheCode 411.4)GCST9004395718.33
157Standing height | Body size measuresUKBB0000079618.22
158COL6A3/OGN ratioGCST9031417718.22
159aparc-a2009s lh thickness S-intrapariet+P-transGCST9000365818.22
160Calcific aortic valve stenosisGCST9031029318.20
161DTI TBSS L3 Superior corona radiata RGCST9038454818.19
162IDP dMRI TBSS L1 Cingulum cingulate gyrus RGCST9000410918.16
163Coxarthrosis, primaryFING0000036318.13
164aparc-a2009s lh area S-calcarineGCST9000334018.12
165TNN levelsGCST9047092718.10
166Height (weighted GWA)GCST9026728517.97
167PLXDC2 levelsGCST9047026417.95
168CEP112 levelsGCST9046870817.83
169DTI TBSS L2 Superior longitudinal fasciculus LGCST9038451717.82
170IDP dMRI ProbtrackX MO atr rGCST9000400317.74
171A body shape indexGCST9002002417.70
172Job involves shift work | EmploymentUKBB0000038517.70
173T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87)GCST9032090617.61
174aparc-Desikan lh area lingualGCST9000308517.59
175FUS levelsGCST9046927817.59
176NGRN levelsGCST9047004517.57
177PCSK9 levelsGCST9047017717.53
178Inguinal hernia | HerniaUKBB0000036317.52
179CTSD/PRCP ratioGCST9031431217.51
180CFB levelsGCST9024077817.50
181HMOX2/TDRKH ratioGCST9031506717.50
182Spinal stenosisFING0000132217.46
183Corneal hysteresis (right) | Intraocular pressureUKBB0000014917.37
184DIABLO/PRKAR1A ratioGCST9031446917.36
185Spinal stenosis of lumbar region (PheCode 720.1)GCST9047623417.32
186Major coronary heart disease eventFING0000074617.28
187Polyunsaturated fatty acids to total fatty acids percentageGCST9050263217.27
188FOXJ3 levelsGCST9046926417.27
189ATRN levelsGCST9046840017.25
190Volume of left basal nucleusGCST9047487717.13
191Corneal resistance factorGCST9010056817.10
192FST/FSTL3 ratioGCST9031488217.07
193Iliac isthmus breadthGCST9044890717.03
194DTI TBSS L3 Superior longitudinal fasciculus LGCST9038456517.01
195HippSubfield lh volume Whole-hippocampal-headGCST9000268817.01
196VSNL1 levelsGCST9047105416.99
197VNN2 levelsGCST9061851016.90
198Plasma succinylcarnitine (C4-DC) levels in chronic kidney diseaseGCST9026599816.85
199Kidney volumeGCST9001667016.83
200Angina pectorisGCST9001857316.81
201PTP4A3 levelsGCST9047037516.79
202IL1RL2 levelsGCST9046957516.75
203Osteoporosis | musculoskeletalUKBB0000059816.68
204ALB levelsGCST9047510016.67
205Polyunsaturated fatty acid levelsGCST9049927116.66
206PDAP1 levelsGCST9047017916.63
207T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST9032094116.62
208IGFBP4/OGN ratioGCST9031513416.61
209Body size (confirmatory factor analysis Factor 21)GCST9030935516.59
210Hippocampal subfield left CA3 volume (body)GCST9026794016.56
211Volume of left whole amygdalaGCST9047489816.54
212Osteoporosis NOS | musculoskeletalUKBB0000059916.49
213FracturesGCST00698016.48
214Lysophosphatidylcholine (22:6) [sn2] levelsGCST9002418516.40
215Angina pectorisFING0000008616.34
216FUCA1 levelsGCST9046927516.29
217aparc-DKTatlas lh area lingualGCST9000324516.27
218LAMB1 levelsGCST9046973216.24
219DTI TBSS L2 Superior fronto-occipital fasciculus RGCST9038451816.24
220Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heelUKBB0000032416.15
221Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heelUKBB0000031816.15
222Coxarthrosis, primary, with hip surgeryFING0000036416.11
223IDP T1 FAST ROIs R hippocampusGCST9000255616.11
224Heel bone mineral density (BMD) | Bone-densitometry of heelUKBB0000031516.08
225Sphingomyelin_42:2_[M+H]1+ levelsGCST9006040316.07
226CST3/IGFBP6 ratioGCST9031429316.05
227Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050216015.97
228CES1 levelsGCST9046871815.95
229Hypermetropia (PheCode 367.8)GCST9047588215.90
230Volume of right basal nucleusGCST9047491015.87
231DTI autoptx MD str r tractGCST9038524415.82
232CC2D1A/STIP1 ratioGCST9031366515.75
233AOC3 levelsGCST9046832215.72
234PON3 levelsGCST9047028715.71
235IDP dMRI TBSS L2 Anterior corona radiata LGCST9000414615.70
236Plasma N-acetyltaurine levels in chronic kidney diseaseGCST9026560015.68
237CardiomyopathyGCST9039970515.67
238Abdominal hernia | digestiveUKBB0000000215.67
239GLRX5 levelsGCST9046936115.66
240ERBB3 levelsGCST9046914015.63
241Adenomyosis (Endometriosis of uterus)FING0000004215.61
242CDON levelsGCST9046868715.59
243SCAMP3/VPS53 ratioGCST9031580715.58
244Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2)GCST9047577015.56
245OXCT1 levelsGCST9047013815.48
246wg lh intensity-contrast temporalpoleGCST9000382415.39
247T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST9032060515.35
248IDP T1 FAST ROIs L parahipp gyrus postGCST9000251915.35
249IL1B levelsGCST9046957015.28
250COL9A1 levelsGCST9046882215.27
251aparc-a2009s rh volume S-oc-middle+LunatusGCST9000305515.23
252ARF6 levelsGCST9046834815.18
253Prescriptions - latanoprost | prostaglandin analogUKBB0000068615.18
254T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11)GCST9032057415.17
255Smoking dependencyFING0000131515.14
256Wears glasses or contact lenses (UKB data field 2207)GCST9004287515.14
257Sleep apnea (MTAG)GCST9026736215.14
258PSME2/RBKS ratioGCST9031573715.11
259Follicular cysts of skin and subcutaneous tissueFING0000054715.09
260Average diameter for VLDL particles (UKB data field 23431)GCST9026952815.06
261Pain type(s) experienced in last month - Back pain | PainUKBB0000062615.05
262LGALS8/SOD2 ratioGCST9031532015.05
263BTD levelsGCST9046847715.03
264T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 107)GCST9032067015.02
265BCL2 levelsGCST9046843315.02
266Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heelUKBB0000032114.97
267Waist-hip indexGCST9002002714.96
268CDHR2 levelsGCST9046867914.96
269Omega-3 fatty acids to total fatty acids percentageGCST9050246314.93
270Chronic osteomyelitis (PheCode 710.12)GCST9047622314.93
271HippSubfield lh volume GC-ML-DG-bodyGCST9000268114.89
272Acute alcohol intoxication, ICD10FING0000001514.88
273Waist-to-hip ratio adjusted for BMIGCST9002002514.88
274Age-related eyesight deterioration (confirmatory factor analysis Factor 27)GCST9030936114.84
275Coronary revascularization (ANGIO or CABG)FING0000036014.82
276Eustachian tube disorders (PheCode 381.2)GCST9047590414.80
277Impedance of arm left (UKB data field 23110)GCST9046817114.79
278Posterior thigh muscle volumeGCST9026735314.78
279Impedance of arm (right) | Impedance measuresUKBB0000035714.73
280T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24)GCST9032058714.72
281BCAN/MOG ratioGCST9031348014.60
282DTI TBSS L3 Retrolenticular part of internal capsule LGCST9038454514.60
283Triglycerides in very large VLDL (UKB data field 23494)GCST9026959114.55
284Volume of right medial nucleusGCST9047492514.53
285Synovitis and tenosynovitis (PheCode 727.1)GCST9047624214.53
286CoxarthrosisFING0000036214.51
287Blood cell traits latent factor 20 (red cell)GCST9055926214.48
288BA-exvivo lh area V2GCST9000321714.47
289Sphingomyelin_42:3_[M+H]1+ levelsGCST9006039914.47
290NCK2/PLA2G4A ratioGCST9031552414.46
291Hand grip strength right (UKB data field 47)GCST9046816914.44
292Cardiomyopathy (PheCode 425)GCST9047594914.39
293T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40)GCST9032085914.33
294Enteritis due to Yersinia enterocoliticaFING0000050514.26
295HippSubfield lh volume GC-ML-DG-headGCST9000267914.25
296Phenylalanine levelsGCST9024340714.25
297Mononeuropathies of upper limb | Nerve, nerve root and plexus disordersUKBB0000048114.22
298HRC levelsGCST9046947514.22
299Tetradecadienedioate (C14:2-DC) metabolite levelGCST9061627514.22
300AmygNuclei lh volume Whole-amygdalaGCST9000265714.17
301Triglyceride levels in chylomicrons and extremely large VLDLGCST9013263014.16
302Inguinal herniaFING0000068114.16
303Corneal resistance factor (right) | Intraocular pressureUKBB0000015114.12
304ACE2 levelsGCST9046819714.10
305SCARA5/TNC ratioGCST9031581014.08
306T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST9032064514.08
307Deforming dorsopathiesFING0000038514.07
308ITGA11 levelsGCST9046963314.07
309IDP dMRI ProbtrackX L3 unc rGCST9000432614.06
310Stroke, excluding SAHFING0000133714.06
311Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB0000007114.06
312FABP5 levelsGCST9046917713.96
313ADGRD1 levelsGCST9046823513.95
314IL22 levelsGCST9008806613.91
315Waist circumference adjusted for body mass indexGCST9002002913.89
316Multi-trait sex scoreGCST9027011813.84
317Octadecanedioylcarnitine (C18-DC) levelsGCST9019999213.84
318aparc-Desikan lh thickness postcentralGCST9000346613.83
319Triglycerides in large VLDL (UKB data field 23501)GCST9026959813.78
320IGFBP6/SMOC2 ratioGCST9031513813.76
321Lung cancerGCST9001181213.74
322Hand grip strength left (UKB data field 46)GCST9046816813.71
323Hand grip strength (baseline)GCST9056584513.64
324F10 levelsGCST9046916313.60
325Atherosclerosis of the extremities (PheCode 440.2)GCST9047599013.53
326Volume of left central nucleusGCST9047488313.52
327aparc-pial lh area pericalcarineGCST9000316113.51
328DLK1/FAP ratioGCST9031449113.50
329wg lh intensity-contrast entorhinalGCST9000379713.50
330aparc-DKTatlas lh thickness postcentralGCST9000356013.49
331TOMM20 levelsGCST9047093113.45
332Omega-3 fatty acids to total fatty acids percentageGCST9050208813.45
333Subpubic angleGCST9044890813.44
334CLEC14A/PIK3IP1 ratioGCST9031408013.41
335Mean volume of bilateral amygdalaGCST9047490113.40
336Pelvic heightGCST9044891213.38
337Total lipids in very large VLDL (UKB data field 23489)GCST9026958613.37
3384-acetamidobutanoate levelsGCST9024344013.36
339Aortic aneurysmFING0000010213.36
340Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivityGCST9030264913.33
341Diaphragmatic herniaFING0000041913.30
342ALB levelsGCST9009280713.30
343aparc-DKTatlas rh area cuneusGCST9000326813.27
344Phospholipids in small VLDLGCST9049988113.26
345Impedance of arm (left) | Impedance measuresUKBB0000035613.26
346GSTA3 levelsGCST9046941213.25
347MAMDC2 levelsGCST9046984113.21
348Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050259213.18
349Polyunsaturated fatty acids to saturated fatty acids ratioGCST9050216613.16
350MYOC levelsGCST9042282513.13
351Sphingomyelin_36:1_[M+H]1+ levelsGCST9006026613.09
352T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST9032090413.09
353Cerebrovascular disease (PheCode 433)GCST9047598513.07
354Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050241013.05
355DTI autoptx L3 slf l tractGCST9038521412.98
356AmygNuclei lh volume Accessory-Basal-nucleusGCST9000265012.90
357Impedance of arm right (UKB data field 23109)GCST9046817212.90
358Familial combined hyperlipidemia defined by Dutch criteriaGCST9010400512.87
359HippSubfield rh volume CA1-headGCST9000269612.86
360Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST9026420712.85
361OtosclerosisFING0000113112.84
362Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB0000006412.82
363Volume of right central nucleusGCST9047491612.78
364DCTN1/ERBIN ratioGCST9031442912.77
365Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST9026970112.75
366Varicose veins of lower extremities | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedUKBB0000089412.74
367aparc-a2009s lh area G-cuneusGCST9000330712.72
368T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST9032089812.72
369Descending aorta diameterGCST9026739112.71
370NIT2 levelsGCST9047005112.69
371Pulse pressureGCST9047278312.65
372Heel bone mineral density (BMD) (right) | Bone-densitometry of heelUKBB0000031412.60
373SNX9/STIP1 ratioGCST9031586412.59
374aparc-Desikan rh area cuneusGCST9000311112.59
375IDP dMRI ProbtrackX L2 fmiGCST9000428412.57
376Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST9019985612.56
377IDP T1 FIRST left hippocampus volumeGCST9000244412.47
378Autorefraction - 6mm strong meridian (left) | EyesightUKBB0000007512.47
379BA-exvivo lh thickness V2GCST9000352312.47
380FLT1/TGFB1 ratioGCST9031485712.47
381Primary/intrinsic cardiomyopathies (PheCode 425.1)GCST9047595112.41
382Whole body water mass (UKB data field 23102)GCST9046818412.39
383Triglycerides in VLDL (UKB data field 23408)GCST9026950512.38
384Medication use (antithrombotic agents)GCST9001876212.35
385Other mental disorders due to brain damage and dysfunction and to physical diseaseFING0000107212.34
386Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heelUKBB0000032312.32
387Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heelUKBB0000031712.32
388aseg global volume-ratio BrainSegVol-to-eTIVGCST9000261212.30
389GAPDH levelsGCST9046930212.28
390Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST9006018812.23
391Illnesses of father - None of the above (group 1) | Family historyUKBB0000034512.19
392TPK1 levelsGCST9047094312.19
393UFC1 levelsGCST9024324512.18
3943-Hydroxybutyrate levelsGCST9009281112.18
395Tibiofemoral angleGCST9027026312.17
396AKT1S1/TDRKH ratioGCST9031323312.16
397Operative procedures - Angiocardiography of left side of heart NEC | Summary OperationsUKBB0000057212.15
398Concentration of very large VLDL particles (UKB data field 23488)GCST9026958512.13
399Wears glasses or contact lenses | EyesightUKBB0000090712.10
400HSPG2/IGFBP6 ratioGCST9031509112.07
401aparc-Desikan rh volume insulaGCST9000283412.07
402Atherosclerosis, excluding cerebral and coronary sclerosisFING0000012312.07
403KeratoconusFING0000070912.03
404aparc-a2009s lh thickness S-postcentralGCST9000366912.03
405wg rh intensity-contrast caudalmiddlefrontalGCST9000383012.02
406Polyunsaturated fatty acid levelsGCST9050213312.02
407Diverticulosis and diverticulitis | digestiveUKBB0000019112.02
408Intra-ocular pressure, corneal-compensated (right) | Intraocular pressureUKBB0000037512.01
409aparc-a2009s lh volume S-centralGCST9000296911.99
410Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST9026958211.96
411X-25371 levelsGCST9020065611.95
412BA-exvivo lh thickness BA2GCST9000351411.92
413Impedance of whole body (UKB data field 23106)GCST9046817311.91
414Free cholesterol in medium VLDLGCST9049896511.91
415aparc-a2009s lh thickness G-postcentralGCST9000363011.90
416Hand grip strength (left) | Hand grip strengthUKBB0000030011.89
417Illnesses of father - Heart disease | Family historyUKBB0000034211.89
418ARHGEF12/IRAK4 ratioGCST9031335011.83
419Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA00000711.79
420Degree of unsaturationGCST9050273611.79
421Stable angina pectorisGCST9001869511.78
422IDP dMRI ProbtrackX L2 ilf lGCST9000428711.78
423BCAM levelsGCST9046842511.76
424DTD1 levelsGCST9046904511.72
425IDP dMRI ProbtrackX MO str lGCST9000402311.69
426Degree of unsaturationGCST9050223111.68
427SUGT1 levelsGCST9047078011.68
428BA-exvivo lh volume entorhinalGCST9000284811.67
429rfMRI amplitudes (ICA100 node 40)GCST9000462811.67
430aparc-Desikan lh area cuneusGCST9000307711.67
431Diverticulosis | digestiveUKBB0000019011.66
432Eye conditions (confirmatory factor analysis Factor 25)GCST9030935911.66
433Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB0000057111.59
434Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9049928811.57
435DCBLD2 levelsGCST9046895211.56
436Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050255411.56
437IDP dMRI TBSS L2 Anterior corona radiata RGCST9000414511.54
438IDP T1 FIRST right putamen volumeGCST9000244111.53
439Polyunsaturated fatty acids to total fatty acids percentageGCST9050217311.52
440Social trust (aggregated)GCST9031931511.52
441SLC27A4/TDRKH ratioGCST9031585111.51
442CFB levelsGCST9046872311.50
443Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU00010511.48
444CMC1 levelsGCST9046879411.47
445DDHD2 levelsGCST9046896811.47
446Forced expiratory volume (baseline)GCST9056584411.46
447GADD45GIP1 levelsGCST9046929311.45
448RAB2B levelsGCST9047040611.44
449DTI autoptx MD slf r tractGCST9038524211.43
450aparc-a2009s lh volume S-calcarineGCST9000296811.42
451AmygNuclei lh volume Central-nucleusGCST9000265211.38
452Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activityUKBB0000087111.36
453Pulse pressureGCST9047278411.34
454IDP dMRI ProbtrackX L3 fmiGCST9000431111.33
455BAX levelsGCST9046842411.32
456Operative procedures - Carpal tunnel release | Summary OperationsUKBB0000057411.31
457aparc-a2009s rh area G-cuneusGCST9000338111.31
458wg lh intensity-contrast caudalmiddlefrontalGCST9000379511.29
459Cholesteryl Esters in Medium VLDLGCST9049893911.28
460Impedance of whole body | Impedance measuresUKBB0000036011.26
461Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)GCST9026955511.26
462NeuroticismGCST00523211.25
463Carotid intima-media thickness (MTAG)GCST9044906111.25
464CYTL1 levelsGCST9046894011.23
465GGCT levelsGCST9046933411.21
466IL17RB levelsGCST9046956311.21
467METAP2 levelsGCST9046989411.19
468RBP5 levelsGCST9047043911.18
469Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levelsGCST9006024311.18
470CD99/MMP3 ratioGCST9031392811.16
471Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB0000007811.15
472Omega-3 fatty acid levelsGCST9050244011.13
473Varicose veins of lower extremity | circulatory systemUKBB0000089511.13
474CD69/NFATC1 ratioGCST9031387911.13
475IDP dMRI TBSS FA Anterior corona radiata LGCST9000390011.12
476T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST9032085511.12
477Myocardial infarction, strictFING0000085211.11
478Octadecenedioylcarnitine (C18:1-DC) levelsGCST9019997011.11
479Tonsillectomy and adenotomyFING0000136711.06
480Diverticular disease of intestine | Other diseases of intestinesUKBB0000018911.06
481AOC3/ITGB1 ratioGCST9031329511.06
482Linoleic acid levelsGCST9049830911.02
483Spinal stenosis (PheCode 720)GCST9047623311.01
484Primary coxarthrosis, bilateralFING0000121211.01
485Impedance of leg (left) | Impedance measuresUKBB0000035811.00
486Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST9026958110.98
487T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST9032057910.98
488Volume of left medial nucleusGCST9047489210.98
489Triglycerides in very small VLDLGCST9050088510.96
490Unstable angina pectorisFING0000140510.95
491T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91)GCST9032065410.94
492T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST9032056510.94
493COL4A1 levelsGCST9046881810.92
494Lung function (FVC)GCST9002599810.90
495Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes)GCST9002770110.90
496Omega-6 fatty acids levelsGCST9049917710.89
497MTDH levelsGCST9046995410.89
498T1 FreeSurfer a2009s lh S postcentral volumeGCST9038488210.89
499Hand grip strength (right) | Hand grip strengthUKBB0000030110.89
500Cholesterol in Medium VLDLGCST9049890310.87
501Mean diameter of VLDL particlesGCST9013273410.86
502TANK levelsGCST9047080310.86
503Autorefraction - 3mm strong meridian (left) | EyesightUKBB0000006510.82
504Autorefraction - 3mm cylindrical power (right) | EyesightUKBB0000006310.82
505Triacylglycerol_46:4_[M+NH4]1+ levelsGCST9006036210.81
506Biological Sibling: Alzheimer's / Other DementiaGCST9047637510.80
507Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)GCST9026958410.80
508Corneal hysteresis (left) | Intraocular pressureUKBB0000014810.77
509IDP dMRI TBSS MD Sagittal stratum LGCST9000405810.75
510Corneal resistance factorGCST9030868210.75
511ANKMY2 levelsGCST9046830910.75
512Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28ECGA00002810.74
513NFU1 levelsGCST9047004010.73
514Haemorrhoidal diseaseGCST9001403310.71
515Disorders of muscle, ligament, and fascia | musculoskeletalUKBB0000018710.70
516Pelvic widthGCST9044891110.70
517T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50)GCST9032061310.69
518aparc-a2009s lh area G-cingul-Post-ventralGCST9000330610.66
519Concentration of large VLDL particles (UKB data field 23495)GCST9026959210.65
520Volume of left accessory basal nucleusGCST9047487410.64
521Colorectal cancer (PheCode 153)GCST00837210.63
522Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T104ECGU00010410.62
523VWA1 levelsGCST9047106110.62
524Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST9026955110.61
525Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae)GCST9002766810.61
526Total lipids in large VLDL (UKB data field 23496)GCST9026959310.60
527DTI TBSS MD Superior fronto-occipital fasciculus LGCST9038461510.59
528Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST9062474410.59
529Luteinizing hormone levelsGCST9048347810.58
530Waist circumference adjusted for body mass indexGCST9030289210.57
531Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heelUKBB0000031610.57
532COL6A3/CST3 ratioGCST9031417410.57
533Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heelUKBB0000032210.57
534COL6A3/SMOC2 ratioGCST9031417810.56
535GPI levelsGCST9046939110.56
536IDP dMRI ProbtrackX FA fmiGCST9000393610.55
537SYTL4 levelsGCST9047079510.55
538Hip indexGCST01222910.53
539Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST9020010310.53
540CLEC1B/VSIR ratioGCST9031410610.53
541Atherosclerosis (PheCode 440)GCST9047598910.51
542ADAMTSL4 levelsGCST9046822910.50
543HDL x low social support interaction (2df test)GCST9057066910.50
544Docosahexaenoic acid to total fatty acids percentageGCST9050228110.49
545Omega-3 fatty acid levelsGCST9050206410.48
546IDP dMRI ProbtrackX MD unc rGCST9000424510.47
547CCN3/FAP ratioGCST9031372110.47
548ICD10 N97.0: Female infertility associated with anovulationGCST9045422310.47
549Cholesterol levels in very large VLDLGCST9050051810.45
550RET levelsGCST9047045810.45
551APPL2 levelsGCST9046834310.44
552Tibia length to body height ratioGCST9027025810.44
553CPXM2 levelsGCST9046885010.43
554Cholesterol in Medium HDLGCST9049849510.38
555MDH1 levelsGCST9046987610.38
556DTI TBSS MD Superior fronto-occipital fasciculus RGCST9038461410.36
557IDP dMRI TBSS L1 Superior longitudinal fasciculus LGCST9000411610.35
558Heel bone mineral density (BMD) (left) | Bone-densitometry of heelUKBB0000031310.32
559Trunk fat-free mass | Impedance measuresUKBB0000086510.30
560Free cholesterol in small VLDLGCST9049980810.29
561BA-exvivo lh thickness BA4aGCST9000351710.29
562Comparative height size at age 10 | Early life factorsUKBB0000014310.28
563Autorefraction - 6mm asymmetry index (left) | EyesightUKBB0000007310.25
564Corneal resistance factor (left) | Intraocular pressureUKBB0000015010.25
565EIF4E levelsGCST9046909610.23
566MSRA/P4HB ratioGCST9031549510.23
567Pulse pressure, automated reading | Cardiovascular measurementUKBB0000071510.21
568DCTN1/FXN ratioGCST9031443010.21
569Androsterone sulfate levelsGCST9020067410.19
570Milk type used: Soy milk vs never have milk (UKB data field 1418)GCST9013294310.19
571Solitary pulmonary nodule (PheCode 514.2)GCST9047604410.18
572Spherical power (left) | AutorefractionUKBB0000079010.15
573Omega-6 fatty acids levelsGCST9049917010.13
574aparc-Desikan lh thickness lateraloccipitalGCST9000345510.09
575Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB0000071910.09
576EFEMP1/FSTL3 ratioGCST9031459510.08
577DTI TBSS L2 Anterior limb of internal capsule RGCST9038449210.08
578RAB11FIP3 levelsGCST9047040410.07
579ACAN levelsGCST9046819610.07
580CSF1/LTBR ratioGCST9031428710.06
581Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST9026957910.06
582VPS4B levelsGCST9047104710.06
583IDP T1 FAST ROIs R putamenGCST9000255210.05
584Phospholipids in very large VLDL (UKB data field 23490)GCST9026958710.04
585TRIAP1 levelsGCST9047096310.01
586Phospholipids in large VLDL (UKB data field 23497)GCST902695949.99
587Trunk predicted mass | Impedance measuresUKBB000008669.97
588MMP8/PGLYRP1 ratioGCST903154659.96
589Speech-in-noise perceptionGCST900447769.96
590CXCL11/CXCL13 ratioGCST903143339.94
591LMNB2 levelsGCST904697829.94
592Triglycerides in small VLDLGCST904999179.94
593Rotator cuff injuryGCST900447009.93
594ICOSLG levelsGCST904695039.92
595QC T1-to-standard nonlinear alignment discrepancyGCST900063469.91
5961-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000759.91
597Omega-3 fatty acid levelsGCST905020629.89
598ITPA levelsGCST904696549.87
599Unstable angina (intermediate coronary syndrome) | circulatory systemUKBB000008839.84
600Polyunsaturated fatty acids to total fatty acids percentageGCST905026449.84
601Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4)GCST904762439.83
602aparc-Desikan lh volume lateraloccipitalGCST900027789.82
603IDP dMRI ProbtrackX ICVF cgh lGCST900043819.80
604LGALS3 levelsGCST904697619.79
605IDP dMRI TBSS ISOVF FornixGCST900044829.79
606Omega-3 fatty acids to total fatty acids percentageGCST905024679.79
607DCTD levelsGCST904689579.78
608IDP dMRI TBSS FA Anterior corona radiata RGCST900038999.77
609Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB000005579.77
610Hip width to body height ratioGCST902702609.76
611IDP dMRI TBSS L1 FornixGCST900040809.76
612HippSubfield lh volume CA4-headGCST900026829.74
613Childhood maltreatmentGCST905518449.73
614NUMB levelsGCST904701089.73
615Autorefraction - 6mm weak meridian (left) | EyesightUKBB000000799.72
616Peak expiratory flow (PEF) | SpirometryUKBB000006389.70
617Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093589.67
618Phospholipids in large VLDLGCST904982479.63
619Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023999.59
620Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695809.59
621Waist-hip indexGCST0122289.59
622LGALS1/LGALS8 ratioGCST903153149.58
623DNA methylation-estimated granulocyte proportionsGCST900142879.57
624Waist-to-hip ratio adjusted for BMIGCST0122309.57
625Holdemania abundance in stoolGCST900324329.56
626IDP dMRI ProbtrackX ICVF unc lGCST900044009.56
627TIMM10 levelsGCST904708679.56
628CFH levelsGCST904687299.56
629Waist circumference adjusted for body mass indexGCST0122269.55
630EPS8L2 levelsGCST904691389.53
631GERD | digestiveUKBB000002839.52
632total creatine kinase (mean, inv-norm transformed)GCST904764139.51
633Heart failure and coronary heart diseaseFING000006049.51
634Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024159.51
635RAB10 levelsGCST904704039.50
636NPL levelsGCST904700729.50
637PFDN5 levelsGCST902423409.49
638SCARA5 levelsGCST904705339.48
639Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695509.47
640End-diastolic bi-ventricular shape (principal component 9)GCST904484889.47
641Concentration of chylomicrons and extremely large VLDL particlesGCST905010109.47
642TNXB levelsGCST904709309.46
643Coronary angioplastyFING000003579.46
644PSAP levelsGCST904265869.43
645GLB1 levelsGCST904693559.43
646COL6A3/TAFA5 ratioGCST903141809.43
647CDK8_CCNC levelsGCST902408259.43
648Phospholipids to total lipids ratio in very small VLDLGCST900930379.42
649Massiliomicrobiota abundance in stoolGCST900324709.42
650IDP dMRI ProbtrackX MO str rGCST900040249.40
651MARS1 levelsGCST904698629.39
652aparc-DKTatlas lh volume parstriangularisGCST900028809.38
653Triglycerides in large LDLGCST904980839.37
654Free cholesterol in large VLDL (UKB data field 23500)GCST902695979.37
655DTI TBSS L2 Retrolenticular part of internal capsule LGCST903844979.36
656Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695329.35
657high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753489.35
658CCL8 levelsGCST904223469.33
659SMAD2 levelsGCST904706769.33
660PRDX5 levelsGCST904703189.32
661Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010929.31
662Free cholesterol in IDLGCST904975619.31
663Eye problems/disorders - None of the above | EyesightUKBB000002329.31
664Asthma mixed form (mode) (more control exclusions)FING000001169.31
665Biliary cirrhosis, NASFING000002139.30
666Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB000007189.30
667Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST902695839.29
668Varicose veins | circulatory systemUKBB000008939.29
669DTI TBSS MD Retrolenticular part of internal capsule LGCST903845939.27
670FADD/NFATC1 ratioGCST903147719.26
671Smoking status - Previous | SmokingUKBB000007819.25
672Congenital malformations of genital organsFING000003339.25
673ATG16L1 levelsGCST904683839.25
674Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695789.24
675Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST902651899.23
676aparc-a2009s rh area G+S-occipital-infGCST900033729.23
677IDP dMRI TBSS L2 Sagittal stratum LGCST900041549.20
678Forced expiratory volume in 1-second (FEV1) | SpirometryUKBB000002519.20
679Omega-3 fatty acid levelsGCST905024379.19
680Monounsaturated fatty acids to total fatty acids percentageGCST904991119.19
681HippSubfield lh volume presubiculum-headGCST900026739.18
682CALCA levelsGCST904685289.18
683Cholesteryl esters in very large VLDLGCST905005529.18
684PCOLCE levelsGCST904701759.17
685PTH1R levelsGCST904703719.17
686Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST902644989.16
687high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753569.15
688Triglycerides in small LDLGCST904997129.14
689aparc-DKTatlas lh thickness lateraloccipitalGCST900035499.13
690aparc-a2009s lh volume G-front-inf-TriangulGCST900029389.13
691CPQ levelsGCST904688469.13
692Whole body fat free mass (UKB data field 23101)GCST904281209.12
693Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903028209.12
694Autorefraction - 3mm weak meridian (left) | EyesightUKBB000000699.12
695DNAJA2/FIS1 ratioGCST903145019.10
696Aneurysm of iliac artery (PheCode 442.2)GCST904759959.10
697Heel broadband ultrasound attenuation (left) | Bone-densitometry of heelUKBB000003199.09
698DTI TBSS L3 Superior corona radiata LGCST903845499.09
699Phospholipids in large VLDLGCST904982439.08
700Coffee difference likingGCST900947389.08
701Phospholipids in medium HDLGCST904986359.08
702Fat-free massGCST0070639.07
703Pelvic inlet widthGCST904489109.03
704GlaucomaGCST904681299.03
705Triglycerides in very large VLDLGCST905006719.03
706Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86ECGU0000869.01
707CCL5/RARRES2 ratioGCST903137049.01
708Volume of left cortical nucleusGCST904748869.01
709Total lipid levels in chylomicrons and extremely large VLDLGCST905010029.01
710Alzheimer's disease (MTAG)GCST904490559.00
711Total triglycerides levels (UKB data field 23407)GCST902695049.00
712Triacylglycerol_46:5_[M+NH4]1+ levelsGCST900603569.00
713BST2/CEACAM1 ratioGCST903135379.00
714Left ventricular end diastole inferoseptal wall thicknessGCST902785149.00
715LTA4H levelsGCST904698128.99
716Sjögren's syndromeGCST900187008.96
717Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006008.95
718Main speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000004198.95
719Free cholesterol in small LDLGCST904996178.94
720wg lh intensity-contrast precentralGCST900038158.93
721Polyunsaturated fatty acids to total fatty acids percentageGCST905026488.93
722Phospholipids in very small VLDLGCST905008518.93
723Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009588.92
724Omega-3 fatty acid levelsGCST905024418.92
725Pulse pressure, automated reading | Cardiovascular measurementUKBB000007148.89
726high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753528.88
727Primary Raynaud’s phenomenonGCST902717148.88
728VAMP8 levelsGCST904710258.87
729Other abnormal uterine and vaginal bleedingFING000009198.86
730Hyperglyceridemia (PheCode 272.12)GCST904757248.86
731PMVK levelsGCST904702728.86
732Phospholipids in small LDLGCST904996738.85
7335alpha-androstan-3beta,17beta-diol disulfate levelsGCST901998358.84
734FKBPL levelsGCST904692468.84
735BA-exvivo rh area V1GCST900032308.83
736NMI levelsGCST904700568.83
737Acetabular diameterGCST904489068.82
738REST UKBBICA NET100 1111GCST903869658.81
739IDP dMRI ProbtrackX MD ilf lGCST900042338.81
740NRGN levelsGCST904700838.80
741FHIT/PRTFDC1 ratioGCST903148238.78
742C21orf58 levelsGCST906183808.77
743Free cholesterol in very large VLDLGCST905005758.77
744TXN levelsGCST904709958.75
745T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903205698.75
746HDL x depression interaction (2df test)GCST905706678.74
747CNPY4 levelsGCST904688008.73
748Benign neoplasm: Colon, unspecifiedFING000001728.73
749Free cholesterol in very large VLDL (UKB data field 23493)GCST902695908.73
750MATN2/SCARA5 ratioGCST903153888.72
751IL1R2 levelsGCST904695728.72
752Omega-3 fatty acids to total fatty acids percentageGCST905024668.71
753ALB levelsGCST902695768.68
754aparc-DKTatlas lh volume lateraloccipitalGCST900028718.67
755IDP dMRI TBSS ICVF Uncinate fasciculus RGCST900043718.67
756Other hammer toe(s) (acquired)FING000010548.67
757Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762688.65
758Angina pectoris (PheCode 411.3)GCST904759338.65
759Free cholesterol in medium LDLGCST904987678.63
760DUT levelsGCST904690548.63
761THTPA levelsGCST904708608.62
762aparc-a2009s lh area G-oc-temp-med-LingualGCST900033188.61
763IDP dMRI ProbtrackX FA atr lGCST900039278.59
764Prescriptions - prostaglandin analogUKBB000006978.59
765Inguinal hernia (PheCode 550.1)GCST904760608.59
766Docosahexaenoic acid levelsGCST905022588.59
767GMFG levelsGCST904693668.58
768CLSTN2/MATN2 ratioGCST903141438.58
769Volume of left anterior amygdaloid areaGCST904748718.58
770Contracture of palmar fascia [Dupuytren's disease] | musculoskeletalUKBB000001468.58
771aparc-DKTatlas lh area lateraloccipitalGCST900032438.58
772aparc-DKTatlas lh thickness cuneusGCST900035438.56
773aparc-pial rh area inferiorparietalGCST900031818.56
774Main speciality of consultant (recoded) - Cardiology | Summary AdministrationUKBB000004148.56
775CCL13/CCL2 ratioGCST903136758.55
776Polyunsaturated fatty acids to total fatty acids percentageGCST905021798.55
777TOP2B levelsGCST904709348.53
778Triglycerides in medium VLDLGCST904990658.52
779T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855348.52
780RAPGEF2 levelsGCST904704268.51
781MRAP levelsGCST900899108.50
782IL3RA levelsGCST904695968.50
783PAMR1 levelsGCST904701558.49
784IDP dMRI TBSS MD External capsule LGCST900040608.49
785Triglycerides in HDLGCST904974648.49
786IDP dMRI ProbtrackX ICVF ar rGCST900043768.48
787GRHPR levelsGCST904694008.47
788Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697308.47
789BA-exvivo lh thickness BA3bGCST900035168.47
790Levulinate 4-oxovalerate levelsGCST902435458.46
791Operation code - squint correction | OperationsUKBB000005668.46
792ERBIN/TBC1D23 ratioGCST903146988.44
793CFHR5 levelsGCST904687288.43
794DTI TBSS MD Superior longitudinal fasciculus RGCST903846128.42
795FOXO1/NFATC1 ratioGCST903148738.42
796Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T11ECGA0000118.42
797Dissection of aortaFING000004678.41
798Fractured/broken bones in last 5 years | Medical conditionsUKBB000002588.41
799ALB levelsGCST904971088.40
800rfMRI connectivity (ICA100 edge 961)GCST900058148.40
801Cholesterol in Small VLDLGCST904997468.39
802Other intervertebral disc disordersFING000010638.39
803X-26109 levelsGCST902006718.38
804Free cholesterol in very small VLDLGCST905007748.38
805IDP dMRI TBSS MD Cingulum cingulate gyrus RGCST900040618.38
806XIAP levelsGCST904710838.36
807HSPB1 levelsGCST904694898.34
808Phenylacetylcarnitine levelsGCST901999938.33
809SEC31A levelsGCST904705638.33
810Autorefraction - 6mm asymmetry angle (left) | EyesightUKBB000000728.31
811Cholesterol esters in very small VLDLGCST905007408.30
812Physical activity (Total log acceleration 8am-10am)GCST900614138.29
813T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71)GCST903206348.28
814Triglycerides to Total Lipids in Small LDL percentageGCST904997408.28
815Autorefraction - 3mm strong meridian (right) | EyesightUKBB000000668.28
816LDLR levelsGCST901793468.28
817Triglycerides in medium LDLGCST904988708.27
818Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009208.27
819Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST902915828.25
820Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000007178.25
821Trigger fingerFING000013768.24
822Phospholipids in large LDLGCST904980538.23
823Unstable angina pectorisGCST900187128.23
824Monounsaturated fatty acid levelsGCST904990908.23
825Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney diseaseGCST902660458.23
826aparc-DKTatlas rh area pericalcarineGCST900032848.22
827IDP dMRI ProbtrackX MD fmiGCST900042308.22
828Triglyceride to HDL cholesterol ratioGCST902959518.22
829IDP dMRI TBSS L2 Superior corona radiata RGCST900041478.22
830Autorefraction - 6mm strong meridian (right) | EyesightUKBB000000768.22
831DTI TBSS L1 Splenium of corpus callosumGCST903844328.20
832Impedance of leg (right) | Impedance measuresUKBB000003598.17
833Cholesterol levels in very small VLDLGCST905007008.17
834Triglycerides in medium VLDL (UKB data field 23508)GCST902696058.16
835CTSH levelsGCST904689138.16
836Glycated hemoglobin levelsGCST905664248.16
837CLMP/TNFRSF19 ratioGCST903141368.15
838Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007218.14
839Lymphoid leukemia, chronic (PheCode 204.12)GCST904756138.13
840IDP dMRI ProbtrackX L2 unc rGCST900042998.13
841Hip indexGCST900200268.13
842Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020778.13
843Volume of right accessory basal nucleusGCST904749078.12
844FGFR2 levelsGCST904692338.11
845COL6A3/COLEC12 ratioGCST903141738.10
846T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903208638.09
847Corneal dystrophy (PheCode 364.5)GCST904758648.09
848Omega-3 fatty acids to total fatty acids percentageGCST905020908.09
849GPIHBP1 levelsGCST904693908.08
850SSC5D levelsGCST904707488.08
851Volume of left medial nucleusGCST904749768.07
852PRTFDC1 levelsGCST904703468.06
853Free cholesterol in large LDLGCST904979818.06
854Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010458.05
855Kidney transplant statusFING000007108.04
856DKKL1 levelsGCST904690008.04
857BOC levelsGCST904684588.04
858total creatine kinase (minimum, inv-norm transformed)GCST904764168.01
859Degree of unsaturationGCST905001758.00
860Autorefraction - 6mm weak meridian (right) | EyesightUKBB000000807.97
861Free cholesterol in very large VLDLGCST905005817.97
862NRP1 levelsGCST904700857.97
863DTI TBSS L2 Superior fronto-occipital fasciculus LGCST903845197.97
864DTI autoptx MD str l tractGCST903852437.97
865Triglycerides to Total Lipids in Very Large HDL percentageGCST905005087.96
866STAT2 levelsGCST904707587.95
867IDP T1 FAST ROIs L hippocampusGCST900025557.94
868SNAP29/TJAP1 ratioGCST903158617.94
869NDUFB7 levelsGCST904700157.93
870CNTN1 levelsGCST904688037.92
871Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024147.92
872TTR levelsGCST904709857.92
873DFFA levelsGCST904689877.90
874NPY levelsGCST904700817.90
875FAM20A levelsGCST904691857.89
876Takes medication for Glaucoma?GCST904753847.87
877C8B levelsGCST904685037.86
878IDP dMRI ProbtrackX L2 atr lGCST900042757.86
879aparc-DKTatlas rh volume lateraloccipitalGCST900029027.85
880Degree of unsaturationGCST905022257.84
881MAP4K5 levelsGCST904698557.79
882Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T16ECGA0000167.78
883aparc-Desikan lh volume parstriangularisGCST900027877.77
884PMVK/PRTFDC1 ratioGCST903156957.77
885Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000000057.76
886DGKA levelsGCST904689897.76
887Corneal edema (PheCode 364.2)GCST904758627.75
888IDP dMRI TBSS L2 Uncinate fasciculus RGCST900041677.75
889CHMP6 levelsGCST904687477.74
890Autorefraction - 3mm weak meridian (right) | EyesightUKBB000000707.74
891Heel bone mineral densityGCST0062887.74
892TNFSF10 levelsGCST900120117.73
893ITGB1 levelsGCST904696437.73
894aparc-Desikan rh area pericalcarineGCST900031277.72
895STROKEFING000013367.72
896ROBO1/SPON1 ratioGCST903157837.71
897Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020697.71
898SMAD1 levelsGCST904706757.71
899Other peripheral nerve disorders | neurologicalUKBB000006187.70
900Subclinical hyperthyroidism in pregnancyGCST904351997.70
901Pulse pressureGCST903102967.68
902Treatment speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000008357.67
903Peripheral vascular diseaseGCST900861347.67
904T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903206237.65
905Right-hemisphere dorsal attention network to pallidum white-matter structural connectivityGCST903028097.65
906Monounsaturated fatty acids to total fatty acids percentageGCST904991097.63
907Triglyceride levels in large VLDLGCST900928787.62
908Dupuytren's diseaseGCST903012527.62
909RBP7 levelsGCST904704407.62
910Average diameter for LDL particlesGCST904984577.62
911Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T68ECGU0000687.61
912DTI TBSS MD Superior longitudinal fasciculus LGCST903846137.61
913Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135ECGU0001357.59
914CLIP2/NT5C3A ratioGCST903141297.59
915Takes medication for coronary artery/ coronary heart disease?GCST904751997.58
916IL31RA levelsGCST904695897.57
917Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST902697217.56
918Operation code - inguinal/femoral hernia repair | OperationsUKBB000005617.55
919ZNRF4 levelsGCST904711047.55
920Non-cancer illness code, self-reported - migraine | Medical conditionsUKBB000005207.54
921Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009297.53
922Triglyceride to phosphoglyceride ratioGCST904544837.53
923Drusen (degenerative) of retina (PheCode 362.27)GCST904758557.53
924A body shape indexGCST0122317.53
925Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006927.53
926Phospholipids in medium LDLGCST904988317.52
927Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85ECGU0000857.52
928PTPRF/PTPRS ratioGCST903157517.52
929Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021477.51
930Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST902697237.50
931JPT2 levelsGCST904696637.50
932ACOT13 levelsGCST904682007.50
933Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST900929407.49
934High density lipoprotein cholesterol levelsGCST902786357.49
935Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182167.47
936IDP dMRI TBSS L1 External capsule LGCST900041087.47
937PPP3R1 levelsGCST904703077.46
938aseg global volume 4th-VentricleGCST900026007.46
939PTPN6/SNAP23 ratioGCST903157477.46
940Corneal opacity and other disorders of cornea (PheCode 364)GCST904758617.45
941Total lipid levels in very large VLDLGCST900930227.44
942IDP T2 FLAIR BIANCA WMH volumeGCST900038627.44
943aparc-DKTatlas lh area cuneusGCST900032377.44
944Concentration of chylomicrons and extremely large VLDL particlesGCST905010157.43
945CD69/SNAP29 ratioGCST903138877.43
946Intracerebral hemorrhageGCST900186507.43
947Cholesteryl Esters in HDLGCST904973687.43
948SMPD1 levelsGCST904706847.42
949IGF1 levelsGCST900259897.42
950Phosphatidylglycerol (34:1) levelsGCST900250617.42
951TNFRSF10A levelsGCST904708997.40
952Ischemic heart disease (PheCode 411)GCST904759297.40
953wg lh intensity-contrast middletemporalGCST900038067.40
954Triglyceride levels in very large VLDLGCST900930267.39
955CCN1 levelsGCST904685877.39
956Arm predicted mass (right) | Impedance measuresUKBB000000507.39
957Omega-3 fatty acid levelsGCST905024367.37
958Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB000005807.37
959Paradoxical eczema in biologic-treated plaque psoriasisGCST901625507.37
960ConstipationFING000003487.37
961Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010917.35
962USP25 levelsGCST904710197.34
963Total lipid levels in chylomicrons and extremely large VLDLGCST905009947.34
964Triglycerides in IDLGCST904976617.33
965Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009837.33
966Treatment speciality of consultant (recoded) - Cardiology | Summary AdministrationUKBB000008297.33
967IDP dMRI ProbtrackX ICVF unc rGCST900044017.33
968IDP dMRI TBSS FA Tapetum RGCST900039237.33
969aparc-Desikan lh thickness paracentralGCST900034617.32
970Triglycerides in very small VLDLGCST905008737.32
971TNFRSF19 levelsGCST904709097.31
972FAM172A levelsGCST904691847.31
973MED18/SMAD1 ratioGCST903154137.31
974Left-hemisphere dorsal attention network to thalamus white-matter structural connectivityGCST903027017.30
975Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009927.30
976Hip circumference adjusted for BMIGCST0122277.29
977Monounsaturated fatty acids to total fatty acids percentageGCST905023727.29
978COLEC12/LTBR ratioGCST903141827.29
979Metabolonic lactone sulfate levelsGCST902002577.28
980Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025667.28
981IDP dMRI TBSS MD Pontine crossing tractGCST900040287.28
982systolic blood pressure (SBP, maximum, inv-normal transformed)GCST904764007.27
983aseg lh volume PutamenGCST900026227.26
984Familial combined hyperlipidemia defined by Consensus criteriaGCST901040067.26
985Alcohol abuse, main dg (more control exclusions)FING000000497.25
986Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000007207.25
987Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763707.25
988Intraocular pressureGCST0040747.25
989Cholesterol in Large LDLGCST904979197.25
990TXNRD1 levelsGCST904709947.24
991AmygNuclei rh volume Medial-nucleusGCST900026637.24
992CALCOCO2 levelsGCST904685317.23
993ALB levelsUKBB000000197.23
994Cholesteryl ester_18:0_[M+NH4]1+ levelsGCST900602227.22
995THBS2 levelsGCST904708547.22
996Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025817.21
997IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040947.21
998Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021537.21
999IDP dMRI ProbtrackX MD fmaGCST900042297.21
1000Spondylolisthesis/SpondylolysisFING000013247.19